American Parkinson Disease Association Releases Symptom Tracker Mobile App With Expanded Features

The American Parkinson Disease Association (APDA) launches today a new and improved APDA Symptom Tracker App 2.0 – a highly-specialized mobile application for people living with Parkinson’s disease (PD). The updated version remains free of charge and features enhanced functionality which will significantly improve the ability of a person with Parkinson’s disease (PD) to easily and accurately track their PD symptoms and medications, and relay that important information to members of their medical team; with the ultimate goal of receiving better, more personalized care.

Read More

La Asociación Americana de Enfermedad de Parkinson lanza la App Diario de síntomas en con funciones ampliadas

The American Parkinson Disease Association (la Asociación Americana de Enfermedad de Parkinson o APDA ) lanza una aplicación nueva y aumentada, la App El Diario de síntomas de la APDA 2.0-una aplicación móvil especializada para personas viviendo con la enfermedad de Parkinson (EP). Esta versión actualizada es gratis y contiene funciones amplificadas para facilitar el seguimiento de los síntomas y medicamentos para las personas con EP, y poder relatar esa información a los miembros de su equipo de atención médica; con la meta de recibir cuidado de salud que es personalizado para cada persona.

Read More

Archived Webinar: Psychiatric Manifestations of Parkinson’s Disease

ARCHIVED: Free Webinar Hosted by University at Albany Aired on: Thursday, July 20, 2017 Watch Here University at Albany hosted a free live webcast for medical and public health professionals, featuring guest speaker Guy J. Schwartz, MD, the Assistant Clinical Professor of Neurology at Stony Brook University Medical Center. In depth, Guy discussed the psychiatric symptoms […]

Read More

World Parkinson Congress 2016

2016 World Parkinson Congress Leadership Forum Before the 4th World Parkinson Congress officially kicked-off in Portland, Oregon nearly 200 Parkinson’s Organizational Partners gathered to network and learn from each other at the first ever WPC Leadership Forum. The Forum allowed PD Advocacy Leaders to talk about their outreach, fundraising, and educational efforts and to strategize […]

Read More

APDA Funded Researcher Published in Journal of Neuroscience – July 2016

APDA funded researcher published in Journal of Neuroscience – July 2016 APDA funded research demonstrates that alpha-synuclein inclusion formation in neurons can be blocked and that novel therapeutic compounds targeting this process by inhibiting LRRK2 kinase activity may slow progression of PD-associated pathology. In 2013 and 2014, APDA awarded research grants to Laura Vopicelli-Daley, PhD, […]

Read More

ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) is now available

The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis is now available through NUPLAZIDconnect™ Patient Access and Support Services The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address […]

Read More

FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin)

FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis U.S. Commercial Launch Planned for June 2016 The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative […]

Read More

Gene Therapy Prevents Parkinson’s Disease in Animal Model, Says Pitt Study

Gene Therapy Prevents Parkinson’s Disease in Animal Model, Says Pitt Study PITTSBURGH, June 15, 2015 – Gene therapy to reduce production of a brain protein successfully prevented development of Parkinson’s disease in an animal study, according to researchers at the University of Pittsburgh School of Medicine. The findings, published online today in the Journal of […]

Read More

APDA Launches Parkinson’s Awareness Training for First Responders

Unique symptoms of Parkinson’s can be mishandled and misunderstood in emergency situations. This new web-based program will educate police, fire fighters and emergency service providers and help save lives. NEW YORK, NY, January 10, 2017 — The American Parkinson Disease Association (APDA) has partnered with the Office of Continuing Professional Education (OCPE) at Rutgers, The […]

Read More

Leslie Chambers, President & Ceo Of APDA To Be Honored By Umass Amherst School Of Public Health And Health Sciences

LESLIE CHAMBERS, PRESIDENT & CEO OF THE AMERICAN PARKINSON DISEASE ASSOCIATION TO BE HONORED BY UMASS AMHERST SCHOOL OF PUBLIC HEALTH AND HEALTH SCIENCES Ms. Chambers to give keynote address at UMass Dean’s Symposium on Parkinson’s and Alzheimer’s Diseases New York, NY, October 12, 2016 – Each year, the University of Massachusetts School of Public […]

Read More